PTGX: Protagonist Therapeutics Inc Market Capitalization
Protagonist Therapeutics (PTGX) delegates drug manufacturing and testing to external contractors to optimize international logistics. Serving as a valuation tool, this chart on GURU.Markets shows a market capitalization of 8.79. Business growth relies on the commercialization of peptide patents through royalties, which reduces costs. A unique research base creates the foundation for success, linking Protagonist Therapeutics (PTGX) with industry leaders through exclusive alliances.
Comprehensive metric breakdowns and analytics for Protagonist Corp (PTGX)
- stock price and consensus target price:
- market capitalization information:
- issuer book value statistics:
- debt and liquidity details:
Total Debt to Capital Protagonist Therapeutics|PTGX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Protagonist Therapeutics|PTGX - Company Aggregate Debts|Debt to Book Capitalization Ratio Protagonist Corp|PTGX - Company Long-Term Loans and Borrowings|Company Short-Term Debt Protagonist Therapeutics|Quick Ratio protagonist-inc.com
- net income and valuation multiples indicators:
PTGX - Net Profit|Future Profit Protagonist Therapeutics|PTGX - Company Value to Net Income|Forward P/E Multiple Protagonist Therapeutics Inc|PTGX - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Protagonist Corp|PTGX - Operating profit before deduction of amortization|Earnings per share for the last twelve months Protagonist Therapeutics|PTGX - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months protagonist-inc.com|PTGX - Earnings growth in current year|Net earnings per share growth forecast for next year Protagonist Therapeutics
Fundamental company analysis:PTGX (Protagonist)
The stability of Protagonist Therapeutics (PTGX) relies on strategic partnerships for the development of peptide drugs, making its market capitalization an accurate gauge of market expectations for future cash flows. This metric, representing the product of the current share price and the total number of issued securities, allows for a real-time assessment of the business's actual value through the company's total equity value, filtering out random market volatility.
Key competitors
argenx - Market Valuation|Market Value BNTX (BioNTech Inc.)|Abivax S.A. - Market Capitalization|Market Capitalization ADMA Corp (ADMA)|IMVT (Immunovant, Inc.) - Market Valuation|Market Capitalization KNSA|Market Value Grifols|Adaptive Biotech - Market Valuation|Market Capitalization CLDX|AUPH (Aurinia Corp) - Market Value|Market Capitalization BCRX (BioCryst)|Market Capitalization veratx.com VERA|DNTH - Market Value|Market Value PHVS (Pharvaris NV)|AbCellera (ABCL) - Market Value|Market Valuation Tourmaline|PGEN (Precigen, Inc.) - Market Capitalization|Market Capitalization pharming.com|Market Valuation NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio, Inc.) - Market Value|Market Capitalization ZBIO (Zenas Biopharma, Inc.)|Market Capitalization Immunome Bio (IMNM)|GOSS - Market Value|kalvista.com (KALV) - Market Valuation|Septerna (SEPN) - Market Value|Market Valuation Pieris Pharma|Market Valuation SVRA|Market Capitalization Rigel Corp|Market Value AnaptysBio, Inc. (ANAB)|astriatx.com - Market Capitalization|Market Capitalization ENGN (enGene)|rapt.com (RAPT) - Market Value|JBIO - Market Value|Market Valuation ACRS|Kyverna Therapeutics (KYTX) - Market Value|tizianalifesciences.com - Market Value|Market Value Cabaletta Bio|Market Value Ventyx Biosciences Inc. VTYX|Market Valuation THTX (Theratechnologies Inc)|Market Value AVTX|Market Capitalization ELDN (Eledon Pharmaceuticals)|Market Capitalization agenusbio.com AGEN|Climb Bio - Market Capitalization|Market Capitalization zurabio.com (ZURA)|aTyr (ATYR) - Market Value|Market Value Adagene Inc. (ADAG)|Market Value ImageneBio|Market Capitalization STTK (Shattuck Therapeutics)|Market Capitalization EQ|Market Capitalization connectbiopharm.com|Market Value Immunic IMUX|Market Capitalization Atara Biotherapeutics, Inc. (ATRA)|IFRX: Market Valuation|x4pharma.com - Market Value|ACET (adicetbio.com) - Market Valuation|Celularity - Market Value|Market Valuation INMB|BRNS (Barinthus Biotherapeutics Corp) - Market Value|Market Capitalization KZR|SABS (sabbiotherapeutics.com) - Market Value|Market Capitalization AKTX (Akari Therapeutics Plc)|Enlivex Therapeutics Ltd (ENLV) - Market Value|QTTB - Market Value|Market Value GOVX (GeoVax Corp)|EDSA: Market Capitalization|ibioinc.com (IBIO) - Market Capitalization|Market Value Carisma Therapeutics Inc|XTL Biopharmaceuticals Ltd - Market Valuation|Market Capitalization BOLT|HCWB - Market Value|Aptevo Therapeutics Inc. - Market Valuation|Market Capitalization aimimmuno.com AIM|ADTX: Market Valuation|GRI Bio Inc - Market Value|XRTX: Market Capitalization|HIND - Market Capitalization|REVB (Revelation Biosciences) - Market Capitalization|Market Valuation indaptusrx.com (INDP)|Market Value Scinai Immunotherapeutics Ltd. (SCNI)|Market Capitalization calcimedica.com|Market Value Affimed N.V. AFMD|ALLK (Allakos Inc) - Market Valuation|HOOK: Market Valuation|IGM Biosciences, Inc. - Market Value|ITOS: Market Capitalization|Market Capitalization Ocean Biomedical Inc OCEA|Market Valuation TCBP|Market Capitalization THRD (Third Harmonic Bio Inc)
